Sugiki Hiroshi, Nakashima Kuniki, Vermes Emmanuelle, Loisance Daniel, Kirsch Matthias
Department of Cardiothoracic Surgery, Henri Mondor Hospital, Créteil, France.
Asian Cardiovasc Thorac Ann. 2009 Aug;17(4):395-400. doi: 10.1177/0218492309338121.
Post-cardiotomy right ventricular failure is a serious complication that frequently results in adverse outcomes. We reviewed our experience with the Impella Recover RD (Impella Cardiosystems GMbH, Aachen, Germany). From January 2007 to December 2007, 7 patients (5 males, 54 +7 years old) had this device implanted for temporary support after heart transplantation in 4, after repeat mitral valve replacement in 2, and with a left ventricular assist device in 1. Devices were implanted during initial operation (n =5) or shortly thereafter (n =2). Six patients underwent implantation without cardiopulmonary bypass. Effective support with pump flows of 4.0-4.5 L x min(-1) and adequate unloading (central venous pressure decreased from 15.3 +/- 1.4 to 9.4 +/- 1.2 mm Hg) was achieved in all patients. Patients were assisted for a mean duration of 4.9 +/- 4.5 days. Three patients could be weaned after 7.0 +/- 5.6 days of support and underwent device explantation without cardiopulmonary bypass. One of these patients died of recurrent right ventricular failure, 2 remained stable but died later of sepsis. The patient with a left ventricular assist device was switched to an alternative device for prolonged support. Two patients experienced pump dysfunction. Our preliminary experience shows that the Impella Recover RD is an effective device that can be easily implanted and explanted. However, its mechanical reliability needs to be improved.
心脏术后右心室衰竭是一种严重并发症,常导致不良后果。我们回顾了使用Impella Recover RD(德国亚琛Impella心脏系统公司)的经验。2007年1月至2007年12月,7例患者(5例男性,年龄54±7岁)植入该装置,其中4例用于心脏移植后的临时支持,2例用于再次二尖瓣置换术后,1例用于左心室辅助装置。装置在初次手术期间植入5例,此后不久植入2例。6例患者在无体外循环情况下植入。所有患者均实现了4.0 - 4.5 L·min⁻¹的泵流量有效支持和充分卸载(中心静脉压从15.3±1.4降至9.4±1.2 mmHg)。患者平均辅助时间为4.9±4.5天。3例患者在支持7.0±5.6天后成功脱机,在无体外循环情况下取出装置。其中1例患者死于复发性右心室衰竭,2例保持稳定但后来死于败血症。植入左心室辅助装置的患者更换为另一种装置以进行长期支持。2例患者出现泵功能障碍。我们的初步经验表明,Impella Recover RD是一种有效的装置,易于植入和取出。然而,其机械可靠性有待提高。